Fisher Patrick 4
4 · Orthofix Medical Inc. · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
Orthofix (OFIX) President Patrick Fisher Sells 1,536 Shares
What Happened
Patrick Fisher, President, Global Limb Recon at Orthofix Medical Inc. (OFIX), sold a total of 1,536 shares in two open-market sell-to-cover transactions to satisfy tax withholding related to the settlement of restricted stock units. He sold 778 shares on 2026-03-04 at a weighted-average price of $12.92 (≈ $10,049) and 758 shares on 2026-03-05 at a weighted-average price of $12.55 (≈ $9,514), for combined proceeds of about $19,563. These were sales (not purchases) and are described as routine tax-withholding transactions rather than discretionary trades.
Key Details
- Transaction dates/prices: 2026-03-04 — 778 sh @ $12.92 (weighted avg; prices ranged $12.80–$13.03 per filing); 2026-03-05 — 758 sh @ $12.55 (weighted avg; prices ranged $12.48–$12.72).
- Total shares sold: 1,536; approximate total proceeds: $19,563.
- Purpose/footnote: Sales made to satisfy tax withholding on RSU settlement pursuant to a pre-existing sell-to-cover requirement approved by the Compensation and Talent Development Committee; sale made without the reporting person’s discretion (Footnote F1).
- Holdings: Filing references 41,134 previously reported restricted stock units (Footnote F3). The filing did not provide a separate post-transaction total common-stock ownership in the materials provided here.
- Filing date/timeliness: Form 4 filed 2026-03-06 (reporting period includes 2026-03-04); filing appears timely (within required reporting window).
Context
Sell-to-cover transactions are common when RSUs vest — the company requires some shares to be sold to cover taxes; these are generally considered administrative/routine and not a directional signal about the executive’s view on the stock. This filing reports ordinary tax-withholding sales rather than discretionary open-market selling under a trading plan.
Insider Transaction Report
- Sale
Common Stock
[F1][F2][F3]2026-03-04$12.92/sh−778$10,049→ 51,391 total - Sale
Common Stock
[F1][F4][F3]2026-03-05$12.55/sh−758$9,514→ 50,633 total
Footnotes (4)
- [F1]Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.80 to $13.03, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4.
- [F3]Includes 41,134 previously reported restricted stock units
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.48 to $12.72, inclusive.